scholarly journals Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.

Gut ◽  
1988 ◽  
Vol 29 (11) ◽  
pp. 1506-1510 ◽  
Author(s):  
S Sahlin ◽  
A Danielsson ◽  
B Angelin ◽  
E Reihner ◽  
R Henriksson ◽  
...  
BMJ ◽  
1992 ◽  
Vol 304 (6842) ◽  
pp. 1611-1612 ◽  
Author(s):  
G. W. Bigg-Wither ◽  
K. K. Ho ◽  
R. R. Grunstein ◽  
C. E. Sullivan ◽  
B. D. Doust

1984 ◽  
Vol 22 (4) ◽  
pp. 13-15

We discussed the dissolution of gallstones with chenodeoxycholic acid (CDCA) (Chendol - CP Pharmaceuticals; Chenofalk - Thames) five years ago.1 Now a second drug, ursodeoxycholic acid (UDCA) (Destolit - Merrell; Ursofalk - Thames) is available for the same purpose. Like CDCA it is given by mouth to dissolve non-calcified cholesterol gallstones in the gallbladder. Several potential advantages are claimed for UDCA; what is its place in treatment?


1992 ◽  
Vol 37 (4) ◽  
pp. 628-630 ◽  
Author(s):  
Joseph P. M. Ellul ◽  
Richard Groves ◽  
Julian R. F. Walters ◽  
Gerard M. Murphy

1985 ◽  
Vol 23 (19) ◽  
pp. 75-76

Rowachol (Tillotts) is a mixture of monoterpenes intended for the dissolution of cholesterol gallstones, as an adjunct to the existing drugs chenodeoxycholic acid (CDCA) and ursodeoxycholic acid (UDCA) whose use we discussed last month.1 When combined with CDCA, Rowachol is claimed to dissolve stones in the common duct. This article assesses its efficacy both alone and in combination therapy.


1990 ◽  
pp. 127-133
Author(s):  
M. Podda ◽  
M. Zuin ◽  
M. L. Petroni ◽  
E. Bertolini ◽  
A. Crosignani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document